BEGIN:VCALENDAR VERSION:2.0 PRODID:-//jEvents 2.0 for Joomla//EN CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VTIMEZONE TZID:America/New_York X-LIC-LOCATION:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:19700308T020000 RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:19701101T020000 RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU END:STANDARD END:VTIMEZONE BEGIN:VEVENT UID:4ee0c630754956d4bd6f182c17dede9551 CATEGORIES:IEC Events (for everyone) SUMMARY:IEC at AAD 2022 - Boston, MA, USA DESCRIPTION:
At AAD 2022 | March 24, 2022 | 2:00-5:30 p m EDT
Boston Convention & Exhibition Center (Bos
ton, MA) | Room 151AB
This symposium will take place prior to the American Academy of Dermatology 2022 Annual Meeting (AA D) in Boston, MA, USA.
PR
OGRAM GOALS
• Analyze the pathophysiology of non-atopic forms
of dermatitis
• Recognize allergic, irritant and protein contact der
matitis in AD patients
• Examine patch testing in AD patients and the
impact of flares and systemic medications
This educational symposium presented by the IEC is offered at no cost t o attendees.
Robert Bissonnette, IE
C President
Robert Bissonnette, MD FRCPC, is Board certified
in dermatology and the president of Innovaderm Research—a contract research
organization (CRO) specializing in the design, conduct, and analysis of cl
inical trials in various areas of dermatology—in Montreal, QC, Canada.
2:00 – 2:10 pm Welcome and Introductions | Robert Bissonnette, IEC President | Montreal , QC, Canada
2:10– 2:40 pm
2:40 – 3:10 pm Allergic contact dermatitis in AD patients< /strong> | Mette Deleuran | Aarhus, Denmark
3:10 – 3:40 pm Irritant contact dermatitis in AD patients |
3:40 – 4:10 pm AD patients with new-onset dermatitis on the face | Eric Simpson | Portland, OR, USA
4:10 – 4:25 pm Break
4:25 – 4:55 pm Patch tes ting in AD patients: impact of flares and system medications | David Cohen | New York, NY, USA
4:55 – 5: 25 pm Panel Discussion and Questions | All Speakers
5:25 – 5:30 pm Closing Comments | Robert Bissonnette | Mon treal, QC, Canada
Please
note IEC will be following AAD/Boston, MA health and safety protocols i
COVID-19 VACCINATION STATUS
Bas
ed on the recent change to the Boston city ordinance on vaccine requirement
s, the AAD will no longer require proof of vaccination to attend the AAD An
nual Meeting. The AAD will continue following all CDC guidelines, as well a
s state, local, and facility regulations.
For those traveling internationally, there may be additional requirements in place. Please check with your airline and current U.S. ent ry guidelines.
MASK MANDATE
Currently, there is
a mask mandate in Boston and at the Boston Convention & Exhibition Cen
ter. We are following all CDC guidelines related to COVID-19 and particular
ly CDC guidelines and convention center recommendations for large group eve
nts.
View additional health and safet y travel resources: https://www.aad .org/member/meetings-education/am22/housing/travel-safety